Literature DB >> 32698130

Real-time, high-resolution imaging of tumor cells in genetically engineered and orthotopic models of thyroid cancer.

Xhesika Shanja-Grabarz1, Anouchka Coste2, David Entenberg2, Antonio Di Cristofano1.   

Abstract

Genetically engineered and orthotopic xenograft mouse models have been instrumental for increasing our understanding of thyroid cancer progression and for the development of novel therapeutic approaches in a setting that is more physiologically relevant than the classical subcutaneous flank implants. However, the anatomical location of the thyroid gland precludes a non-invasive analysis at the cellular level of the interactions between tumor cells and the surrounding microenvironment and does not allow a real-time evaluation of the response of tumor cells to drug treatments. As a consequence, such studies have generally only relied on endpoint approaches, limiting the amount and depth of the information that could be gathered. Here we describe the development of an innovative approach to imaging specific aspects of thyroid cancer biology, based on the implantation of a permanent, minimally invasive optical window that allows high-resolution, multi-day, intravital imaging of the behavior and cellular dynamics of thyroid tumors in the mouse. We show that this technology allows visualization of fluorescently tagged tumor cells both in immunocompetent, genetically engineered mouse models of anaplastic thyroid cancer (ATC) and in immunocompromised mice carrying orthotopic implanted human or mouse ATC cells. Furthermore, the use of recipient mice in which endothelial cells and macrophages are fluorescently labeled allows the detection of the spatial and functional relationship between tumor cells and their microenvironment. Finally, we show that ATC cells expressing a fluorescent biosensor for caspase 3 activity can be effectively utilized to evaluate, in real-time, the efficacy and kinetics of action of novel small molecule therapeutics. This novel approach to intravital imaging of thyroid cancer represents a platform that will allow, for the first time, the longitudinal, in situ analysis of tumor cell responses to therapy and of their interaction with the microenvironment.

Entities:  

Keywords:  apoptosis; high-resolution; imaging; mouse models; thyroid cancer

Year:  2020        PMID: 32698130      PMCID: PMC7450603          DOI: 10.1530/ERC-20-0295

Source DB:  PubMed          Journal:  Endocr Relat Cancer        ISSN: 1351-0088            Impact factor:   5.678


  39 in total

Review 1.  Tumor microenvironment: Sanctuary of the devil.

Authors:  Lanlan Hui; Ye Chen
Journal:  Cancer Lett       Date:  2015-08-11       Impact factor: 8.679

2.  Intravital 2-photon imaging reveals distinct morphology and infiltrative properties of glioblastoma-associated macrophages.

Authors:  Zhihong Chen; James L Ross; Dolores Hambardzumyan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-06-24       Impact factor: 11.205

3.  Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.

Authors:  Iñigo Landa; Tihana Ibrahimpasic; Laura Boucai; Rileen Sinha; Jeffrey A Knauf; Ronak H Shah; Snjezana Dogan; Julio C Ricarte-Filho; Gnana P Krishnamoorthy; Bin Xu; Nikolaus Schultz; Michael F Berger; Chris Sander; Barry S Taylor; Ronald Ghossein; Ian Ganly; James A Fagin
Journal:  J Clin Invest       Date:  2016-02-15       Impact factor: 14.808

4.  Primary tumor dependent inhibition of tumor growth, angiogenesis, and perfusion of secondary breast cancer in bone.

Authors:  Christian Schaefer; Malte Schroeder; Ina Fuhrhop; Lennart Viezens; Jasmin Otten; Walter Fiedler; Wolfgang Rüther; Nils Hansen-Algenstaedt
Journal:  J Orthop Res       Date:  2011-03-04       Impact factor: 3.494

5.  Expression of Gal4-dependent transgenes in cells of the mononuclear phagocyte system labeled with enhanced cyan fluorescent protein using Csf1r-Gal4VP16/UAS-ECFP double-transgenic mice.

Authors:  Dmitry A Ovchinnikov; Wendy J M van Zuylen; Claire E E DeBats; Kylie A Alexander; Stuart Kellie; David A Hume
Journal:  J Leukoc Biol       Date:  2007-10-30       Impact factor: 4.962

Review 6.  Intravital Imaging Techniques for Biomedical and Clinical Research.

Authors:  Anouchka Coste; Maja H Oktay; John S Condeelis; David Entenberg
Journal:  Cytometry A       Date:  2019-12-30       Impact factor: 4.355

7.  Dual inhibition of BCL-XL and MCL-1 is required to induce tumour regression in lung squamous cell carcinomas sensitive to FGFR inhibition.

Authors:  Clare E Weeden; Casey Ah-Cann; Aliaksei Z Holik; Julie Pasquet; Jean-Marc Garnier; Delphine Merino; Guillaume Lessene; Marie-Liesse Asselin-Labat
Journal:  Oncogene       Date:  2018-05-10       Impact factor: 9.867

8.  Platelet GPIbα is a mediator and potential interventional target for NASH and subsequent liver cancer.

Authors:  Mohsen Malehmir; Dominik Pfister; Suchira Gallage; Marta Szydlowska; Donato Inverso; Elena Kotsiliti; Valentina Leone; Moritz Peiseler; Bas G J Surewaard; Dominik Rath; Adnan Ali; Monika Julia Wolf; Hannah Drescher; Marc E Healy; Daniel Dauch; Daniela Kroy; Oliver Krenkel; Marlene Kohlhepp; Thomas Engleitner; Alexander Olkus; Tjeerd Sijmonsma; Julia Volz; Carsten Deppermann; David Stegner; Patrick Helbling; César Nombela-Arrieta; Anahita Rafiei; Martina Hinterleitner; Marcel Rall; Florian Baku; Oliver Borst; Caroline L Wilson; Jack Leslie; Tracy O'Connor; Christopher J Weston; Abhishek Chauhan; David H Adams; Lozan Sheriff; Ana Teijeiro; Marco Prinz; Ruzhica Bogeska; Natasha Anstee; Malte N Bongers; Mike Notohamiprodjo; Tobias Geisler; Dominic J Withers; Jerry Ware; Derek A Mann; Hellmut G Augustin; Alexandros Vegiopoulos; Michael D Milsom; Adam J Rose; Patricia F Lalor; Josep M Llovet; Roser Pinyol; Frank Tacke; Roland Rad; Matthias Matter; Nabil Djouder; Paul Kubes; Percy A Knolle; Kristian Unger; Lars Zender; Bernhard Nieswandt; Meinrad Gawaz; Achim Weber; Mathias Heikenwalder
Journal:  Nat Med       Date:  2019-04-01       Impact factor: 53.440

9.  Thyrocyte-specific inactivation of p53 and Pten results in anaplastic thyroid carcinomas faithfully recapitulating human tumors.

Authors:  Valeria G Antico Arciuch; Marika A Russo; Mariavittoria Dima; Kristy S Kang; Florence Dasrath; Xiao-Hui Liao; Samuel Refetoff; Cristina Montagna; Antonio Di Cristofano
Journal:  Oncotarget       Date:  2011-12

10.  Discovery of Mcl-1-specific inhibitor AZD5991 and preclinical activity in multiple myeloma and acute myeloid leukemia.

Authors:  Adriana E Tron; Matthew A Belmonte; Ammar Adam; Brian M Aquila; Lawrence H Boise; Elisabetta Chiarparin; Justin Cidado; Kevin J Embrey; Eric Gangl; Francis D Gibbons; Gareth P Gregory; David Hargreaves; J Adam Hendricks; Jeffrey W Johannes; Ricky W Johnstone; Steven L Kazmirski; Jason G Kettle; Michelle L Lamb; Shannon M Matulis; Ajay K Nooka; Martin J Packer; Bo Peng; Philip B Rawlins; Daniel W Robbins; Alwin G Schuller; Nancy Su; Wenzhan Yang; Qing Ye; Xiaolan Zheng; J Paul Secrist; Edwin A Clark; David M Wilson; Stephen E Fawell; Alexander W Hird
Journal:  Nat Commun       Date:  2018-12-17       Impact factor: 14.919

View more
  2 in total

1.  The Year in Basic Thyroid Cancer Research.

Authors:  Antonio Di Cristofano
Journal:  Thyroid       Date:  2021-12-16       Impact factor: 6.506

2.  SWIP-a stabilized window for intravital imaging of the murine pancreas.

Authors:  Wei Du; Christian Adkisson; Xianjun Ye; Camille L Duran; Benson Chellakkan Selvanesan; Claudia Gravekamp; Maja H Oktay; John C McAuliffe; John S Condeelis; Nicole C Panarelli; Robert J Norgard; Yogev Sela; Ben Z Stanger; David Entenberg
Journal:  Open Biol       Date:  2022-06-15       Impact factor: 7.124

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.